Prasad’s claim of 10 Covid vaccine deaths may be an overcount: FDA sourcesnews2025-12-04T17:54:14+00:00December 4th, 2025|Endpoints News|
Trump administration pushes end-of-term deadline for ‘most favored nation’ promisesnews2025-12-04T16:10:15+00:00December 4th, 2025|Endpoints News|
UniQure restates FDA’s negative feedback on Huntington’s trial; Neurimmune’s expanded AstraZeneca alliancenews2025-12-04T15:06:59+00:00December 4th, 2025|Endpoints News|
BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand news2025-12-04T15:01:36+00:00December 4th, 2025|Endpoints News|
Crescent forms PD-1xVEGF, ADC pact with Kelun, raises $185Mnews2025-12-04T14:04:35+00:00December 4th, 2025|Endpoints News|
Nationwide Children’s SLC6A1 gene therapy shows early promisenews2025-12-04T13:00:54+00:00December 4th, 2025|Endpoints News|
ARCH, Lilly Asia Ventures return to back US-China startup SciNeuronews2025-12-04T12:00:42+00:00December 4th, 2025|Endpoints News|
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagennews2025-12-04T11:59:37+00:00December 4th, 2025|Endpoints News|
Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatironnews2025-12-04T11:00:00+00:00December 4th, 2025|Endpoints News|
Home care startup Inbound Health shuts downnews2025-12-04T02:28:00+00:00December 4th, 2025|Endpoints News|
